Patents by Inventor Chan Wha Kim

Chan Wha Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COSMETIC COMPOSITION CONTAINING, AS ACTIVE INGREDIENT, ALBUMIN, HYALURONIC ACID OR COLLAGEN IN CELL CULTURE MEDIUM
    Publication number: 20210353519
    Abstract: A composition contains a cell culture medium and, as an active ingredient, albumin, hyaluronic acid or collagen. The composition is useful as a cosmetic or pharmaceutical purpose for alleviating, preventing or treating skin wounds, skin diseases or skin conditions, by enhancing recovery capability of cells. The cell culture medium may be a serum-free medium.
    Type: Application
    Filed: May 28, 2021
    Publication date: November 18, 2021
    Applicant: BIOCOZ GLOBAL KOREA CORP.
    Inventors: Chan Wha KIM, Young Joon KIM
  • Cosmetic composition containing, as active ingredient, albumin, hyaluronic acid or collagen in cell culture medium
    Patent number: 11071706
    Abstract: The present invention relates to a cosmetic or pharmaceutical composition containing a cell culture medium and, as an active ingredient, albumin, hyaluronic acid or collagen. The composition according to the present invention can be useful as a cosmetic or pharmaceutical composition for alleviating, preventing or treating skin wounds, skin diseases or skin conditions, by increasing the recovery capability of cells.
    Type: Grant
    Filed: March 31, 2017
    Date of Patent: July 27, 2021
    Assignee: BIOCOZ GLOBAL KOREA CORP.
    Inventors: Chan Wha Kim, Young Joon Kim
  • Cosmetic composition for improving condition of skin, containing cell culture medium, epidermal growth factor and bovine serum albumin
    Patent number: 10801009
    Abstract: The present invention relates to: a cosmetic composition for improving the condition of the skin, containing, as active ingredients, a cell culture medium, an epidermal growth factor and a bovine serum albumin; a method for improving the condition of the skin by using the same; and a method for preventing or treating skin diseases. According to the present invention, the cosmetic composition can exhibit excellent wrinkle-reducing and wound-healing effects even when only a small amount of EGF is used, and thus can be useful in improving the condition of the skin or in preventing or treating skin diseases.
    Type: Grant
    Filed: November 17, 2015
    Date of Patent: October 13, 2020
    Assignee: BIOCOZ GLOBAL KOREA CORP.
    Inventors: Chan Wha Kim, Young Joon Kim, Hyun Jung Kim
  • COSMETIC COMPOSITION CONTAINING, AS ACTIVE INGREDIENT, ALBUMIN, HYALURONIC ACID OR COLLAGEN IN CELL CULTURE MEDIUM
    Publication number: 20200297613
    Abstract: The present invention relates to a cosmetic or pharmaceutical composition containing a cell culture medium and, as an active ingredient, albumin, hyaluronic acid or collagen. The composition according to the present invention can be useful as a cosmetic or pharmaceutical composition for alleviating, preventing or treating skin wounds, skin diseases or skin conditions, by increasing the recovery capability of cells.
    Type: Application
    Filed: March 31, 2017
    Publication date: September 24, 2020
    Applicant: BIOCOZ GLOBAL KOREA CORP.
    Inventors: Chan Wha KIM, Young Joon KIM
  • COSMETIC COMPOSITION FOR IMPROVING CONDITION OF SKIN, CONTAINING CELL CULTURE MEDIUM, EPIDERMAL GROWTH FACTOR AND BOVINE SERUM ALBUMIN
    Publication number: 20170355952
    Abstract: The present invention relates to: a cosmetic composition for improving the condition of the skin, containing, as active ingredients, a cell culture medium, an epidermal growth factor and a bovine serum albumin; a method for improving the condition of the skin by using the same; and a method for preventing or treating skin diseases. According to the present invention, the cosmetic composition can exhibit excellent wrinkle-reducing and wound-healing effects even when only a small amount of EGF is used, and thus can be useful in improving the condition of the skin or in preventing or treating skin diseases.
    Type: Application
    Filed: November 17, 2015
    Publication date: December 14, 2017
    Applicant: BIOCOZ GLOBAL KOREA CORP.
    Inventors: Chan Wha KIM, Young Joon KIM, Hyun Jung KIM
  • BIO-MARKERS FOR DIAGNOSING DIABETIC RETINOPATHY
    Publication number: 20110269248
    Abstract: Disclosed herein are bio-markers for diagnosing diabetic retinopathy, a use of proteins, whose expression level down-regulated or up-regulated in the tears of a non-proliferative diabetic retinopathy (NPDR) patient, as bio-markers for diagnosing diabetic retinopathy, and a composition and kit for diagnosing diabetic retinopathy comprising antibodies against said proteins.
    Type: Application
    Filed: July 14, 2011
    Publication date: November 3, 2011
    Applicant: Korea University Research and Business Foundation
    Inventors: Chan Wha KIM, Hyunsyuk Yoo, Jae-Chan Kim, Pan Kyeom Kim, Hye Won Park, Mi Ryung Kim
  • Bio-Markers For Diagnosing Diabetic Retinopathy
    Publication number: 20090186032
    Abstract: Disclosed herein are bio-markers for diagnosing diabetic retinopathy, a use of proteins, whose expression level down-regulated or up-regulated in the tears of a non-proliferative diabetic retinopathy (NPDR) patient, as bio-markers for diagnosing diabetic retinopathy, and a composition and kit for diagnosing diabetic retinopathy comprising antibodies against said proteins.
    Type: Application
    Filed: January 16, 2009
    Publication date: July 23, 2009
    Applicant: Korea University Research and Business Foundation
    Inventors: Chan Wha Kim, Hyunsyuk Yoo, Jae-Chan Kim, Pan Kyeom Kim, Hye Won Park, Mi Ryung Kim